A startup with a dedicated R&D budget
It is an acrimonious exchange: a tumour in the eloquent brain, and the potential insight and information that electrical brain mapping might yield during its removal.
It is unmistakeable that brain tumour patients have inadvertently provided a circumstance permissible to the wider understanding of neurocognitive function, often at the expense of an unfair and unfortunate prognosis.
As doctors, surgeons and scientists are slowly beginning to understand how the brain might be organised, and under which circumstances it is capable of reorganising itself, treatment paradigms in neuro-oncological surgery are evolving with the information gathered in its wake.
Clinical neuroscientists employed by Neuroclast take great pride, and consider it a great privilege, to engage in the work they do from day-to-day. The journeys of our patients, and our clinicians, is what motivates us to continue to explore important clinical opportunities that might help others.
We are facilitators
NCX is our research and development program, where we fuse our clinical observations following recognition of clinical and investigational needs that we can dedicate resources to exploring.
As a solutions-focused healthcare company, we feel that it is our duty to collect data in a way that contributes to the sharing of techniques, outcomes and philosophies as it relates to clinical neuroscience and education.
Our relationships with clinicians is what motivates us to pursue meaningful and original contributions to peer-reviewed clinical research. If we are able to facilitate data collection for an outcomes study, or contribute to the design of new paradigms in clinical neuroscience, we would take great pride in exploring these with you and your team.
We don't offer this as a "consulting service", this is what comes with partnering with our team. If there is a surplus left over from our R&D budget, we will look towards creating a cumulative budget, or philanthropic efforts.
Feel free to contact us if you recognise an opportunity to work together in applications relating to: clinical neurophysiology, clinical neuroscience, brain mapping, deep brain stimulation, transcranial magnetic stimulation, product development or clinical workshops.
With an outcomes focus
Our current research projects are tailored to product-related clinical applications as we seek to establish ANZ-first studies pertaining to invasive and non-invasive brain mapping in brain tumour surgery. Please contact us if you'd like to discuss your involvement in our research.
Current Research Projects:
Spatial accuracy of EnTMS data of motor and language regions compared with direct cortical stimulation data
EnTMS language mapping and candidacy for asleep craniotomy.
Pre-operative risk stratification of motor and language systems in supratentorial glioma surgery (pathology type subgroups)
EnTMS and pre-operative planning: does it impact extent of resection, reduce craniotomy size, time for direct cortical stimulation, incidence of seizures.
Functional seed points for DTI-FT compared with anatomic seed points (double blind)
Patient experiences with non-invasive brain stimulation; tolerability, psychological impact.
Integration of hapticVR and clinical training for aspects of 'pre-competency'
Long-term Research Aims:
EnTMS and 'prehabilitation' in lower grade glioma patients
Physical re-mapping of functional reorganisation in lower grade glioma patients following surgical resection
Repetitive EnTMS for rehabilitation of neural function following surgery.
Diagnostic quality of EnTMS for cervical central stenosis & subsequent risk stratification.
EnTMS & EEG for exploration of neural networks linked to event related potentials.
Functional brain mapping as a validation tool for connectomic modelling.